237
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxicity and maternal toxicity attributed to exposure to Momordica charantia L. (Cucurbitaceae) dry leaf extract

, , , , , , , , ORCID Icon & ORCID Icon show all

References

  • Abd El Sattar El Batran, S., S. E. El-Gengaihi, and O. A. El Shabrawy. 2006. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J. Ethnopharmacol 108 (2):236–42. doi:10.1016/j.jep.2006.05.015.
  • Adewale, O. O., O. I. Oduyemi, and O. Ayokunle. 2014. Oral administration of leaf extracts of Momordica charantia affect reproductive hormones of adult female Wistar rats. Asian Pac. J. Trop Biomed 4 (Suppl 1):S521–24. doi:10.12980/APJTB.4.2014C939.
  • Agrawal, R. C., and T. Beohar. 2010. Chemopreventive and anticarcinogenic effects of Momordica charantia extract. Asian Pac. J. Cancer Prev. 11 (2):371–75.
  • Anvisa. 2013. Guia para a condução de estudos não clínicos de segurança farmacológica necessários ao desenvolvimento de medicamentos, 48. 2nd ed. Brasília, DF: Brazilian National Health Surveillance Agency https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/medicamentos/pesquisa-clinica/manuais-e-guias/guia-para-a-conducao-de-estudos-nao-clinicos-de-toxicologia-e-seguranca-farmacologica-necessarios-ao-desenvolvimento-de-medicamentos-versao-2.pdf/view
  • Bakare, R. I., O. A. Magbagbeola, A. I. Akinwande, and O. A. Ebuehi. 2010. Effect of aqueous leaf extract of Momordica charantia on intestinal enzyme activities in diarrhoeagenic mice. Nig. Q J. Hosp. Med 20 (1):24–28.
  • Bakare, R. I., O. A. Magbagbeola, A. I. Akinwande, O. W. Okunowo, and M. Green. 2011. Antidiarrhoeal activity of aqueous leaf extract of Momordica charantia in rats. J. Pharmacognosy Phytother. 3:1–7. doi:10.5897/JPP.9000010.
  • Bonciu, E., P. Firbas, C. S. Fontanetti, J. Wusheng, M. C. Karaismailoğlu, D. Liu, F. Menicucci, D. S. Pesnya, A. Popescu, A. V. Romanovsky, et al. 2018. An evaluation for the standardization of the Allium cepa test as cytotoxicity and genotoxicity assay. Caryologia 71 (3):191–209. doi:10.1080/00087114.2018.1503496.
  • Bortolotti, M., D. Mercatelli, and L. Polito. 2019. Momordica charantia, a nutraceutical approach for inflammatory related diseases. Front Pharmacol. 10:486. doi:10.3389/fphar.2019.00486.
  • Brasil. 2019. Agência Nacional de Vigilância Sanitária. Farmacopeia Brasileira. Brasília: ANVISA.
  • Brown, A. S., J. van Os, C. Driessens, H. W. Hoek, and E. S. Susser. 2000. Further evidence of relation between prenatal famine and major affective disorder. Am. J. Psychiat. 157 (2):190–95. doi:10.1176/appi.ajp.157.2.190.
  • Cardoso, B. S., K. B. Machado, J. R. de Paulade Paula, J. A. M. de Paula, W. M. Cuvinel, and V. C. S. Amaral. 2017. Developmental toxicity evaluation of Pimenta pseudocaryophyllus (Gomes) Landrum, (E)-methyl isoeugenol chemotype, in Wistar rats. Birth Defects Res. 109 (16):1292–300. doi:10.1002/bdr2.1075.
  • Carney, E. W., and C. A. Kimmel. 2007. Interpretation of skeletal variations for human risk assessment: Delayed ossification and wavy ribs. Birth Defects Res. B Dev. Reprod. Toxicol. 80 (6):473–96. doi:10.1002/bdrb.20133.
  • Chan, W. Y., P. P. Tam, and H. W. Yeung. 1984. The termination of early pregnancy in the mouse by β-momorcharin. Contraception 29 (1):91–100. doi:10.1016/0010-7824(84)90062-3.
  • Chernoff, N., and J. M. Rogers. 2004. Supernumerary ribs in developmental toxicity bioassays and in human populations: Incidence and biological significance. J. Toxicol. Environ. Health B 7 (6):437–49. doi:10.1080/10937400490512447.
  • Chokki, M., M. Cudălbeanu, C. Zongo, D. Dah-Nouvlessounon, I. O. Ghinea, B. Furdui, R. Raclea, A. Savadogo, L. Baba-Moussa, S. M. Avamesc, et al. 2020. Exploring antioxidant and enzymes (a-amylase and b-glucosidase) inhibitory activity of Morinda lucida and Momordica charantia leaves from Benin. Foods 9 (4):434. doi:10.3390/foods9040434.
  • Chuang, L. T., Y. H. Shih, W. C. Huang, L. C. Lin, C. Hsu, J. H. Chyuan, T. H. Tsai, and P. J. Tsai. 2020. In vitro and in vivo screening of wild bitter melon leaf for anti-inflammatory activity against Cutibacterium acnes. Molecules 25:4277. doi:10.3390/molecules25184277.
  • Costa, A. F. 2001. Farmacognosia. 3rd ed. Lisboa: F. Calouste Gulbenkian.
  • Ehigie, A. F., P. Wei, T. Wei, X. Yan, O. O. Olorunsogo, F. D. Ojeniyi, and L. O. Ehigie. 2021. Momordica charantia L. induces non-apoptotic cell death in human MDA-MB-436 breast and A549 lung cancer cells by disrupting energy metabolism and exacerbating reactive oxygen species' generation. J Ethnopharmacol 277:114036. doi:10.1016/j.jep.2021.114036.
  • Elekofehinti, O. O., E. O. Ariyo, M. O. Akinjiyan, O. S. Olayeriju, A. O. Lawal, I. G. Adanlawo, and J. B. T. Rocha. 2018. Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology 25 (4):327–33. doi:10.1016/j.pathophys.2018.05.003.
  • Ferreira, T. M. S., J. A. Santos, L. A. Modesto, L. S. Souza, M. P. V. Santos, D. G. Bezerra, and J. A. M. Paula. 2019. An eco-friendly method for extraction and quantification of flavonoids in Dysphania ambrosioides. Rev bras farmacogn 29:266–70. doi:10.1016/j.bjp.2019.01.004.
  • Fiskesjö, G. 1985. The Allium test as a standard in environmental monitoring. Hereditas 102 (1):99–112. doi:10.1111/j.1601-5223.1985.tb00471.x.
  • Freire, J. S., B. C. S. Fernandes, J. A. C. Silva, J. R. S. Araujo, P. M. Almeida, J. S. Costa, J. N. Silva, S. D. L. Freitas, and F. A. Martins. 2020. Phytochemical and antioxidant characterization, cytogenotoxicity and antigenotoxicity of the fractions of the ethanolic extract of in Poincianella bracteosa (Tul.) L.P. Queiroz. J. Toxicol. Environ. Health Part A 83 (23–24):730–47. doi:10.1080/15287394.2020.1824136.
  • Gandhi, P. R., C. Jayaseelan, R. R. Mary, D. Mathivanan, and S. R. Suseem. 2017. Acaricidal, pediculicidal and larvicidal activity of synthesized ZnO nanoparticles using Momordica charantia leaf extract against blood feeding parasites. Exp. Parasitol. 181:47–56. doi:10.1016/j.exppara.2017.07.007.
  • Ganeshpurkar, A., and A. K. Saluja. 2017. The pharmacological potential of rutin. Saudi Pharm. J. 25 (2):149–64. doi:10.1016/j.jsps.2016.04.025.
  • Hammer, Ø., D. A. T. Harper, and P. D. Ryan. 2001. PAST: Paleontological statistics software package for education and data analysis. Palaeontol. Electronica. 4:4–9.
  • He, Q., Y. Li, H. Li, P. Zhang, A. Zhang, L. You, H. Wu, P. Xiao, and J. Liu. 2018. Hypolipidemic and antioxidant potential of bitter gourd (Momordica charantia L.) leaf in mice fed on a high-fat diet. Pak. J. Pharm. Sci. 31 (5):1837–43.
  • Horcajada-Molteni, M. N., V. Crespy, V. Coxam, M. J. Davicco, C. Rémésy, and J. P. Barlet. 2000. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res. 15 (11):2251–58. doi:10.1359/jbmr.2000.15.11.2251.
  • Hsiao, P. C., C. C. Liaw, S. Y. Hwang, H. L. Cheng, L. J. Zhang, C. C. Shen, F. L. Hsu, and Y. H. Kuo. 2013. Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia. J. Agric. Food Chem. 61 (12):2979–86. doi:10.1021/jf3041116.
  • Huber, L. S., and D. B. Rodriguez-Amaya. 2008. Flavonois e flavonas: fontes brasileiras e fatores que influenciam a composição em alimentos. Alim Nutr 19:97–108.
  • Husna, R. N., A. Noriham, H. Nooraain, A. H. Azizah, and O. Farah Amna. 2013. Acute oral toxicity effects of Momordica charantia in Sprague Dawley rats. Int. J. Biosci. Biochem. Bioinform. 3:408–10. doi:10.7763/IJBBB.2013.V3.244.
  • Jia, S., M. Shen, F. Zhang, and J. Xie. 2017. Recent advances in Momordica charantia: Functional components and biological activities. Int. J. Mol. Sci. 18 (12):2555. doi:10.3390/ijms18122555.
  • Kanpalta, F., D. Ozbeyli, A. Sem, O. Cevik, G. Sener, and F. Ercan. 2021. Bitter melon (Momordica charantia) fruit extract ameliorates methotrexate‐induced reproductive toxicity in male rats. Marmara Med. J. 34:222–28. doi:10.5472/marumj.988941.
  • Kelly, W. L., and M. M. Bryden. 1983. A modified differential stain for cartilage and bone in whole mount preparations of mammalian fetuses and small vertebrates. Stain Technol. 58 (3):131–34. doi:10.3109/10520298309066773.
  • Khan, M. F., N. Abutaha, F. A. Nasr, A. S. Alqahtani, O. M. Noman, and M. A. Wadaan. 2019. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos. BMC Complement Altern Med. 19 (1):184. doi:10.1186/s12906-019-2599-0.
  • Khera, K. S. 1981. Common fetal aberrations and their teratologic significance: A review. Fundam. Appl. Toxicol. 1 (1):13–18. doi:10.1093/toxsci/1.1.13.
  • Khera, K. S. 1984. Maternal toxicity - a possible factor in fetal malformations in mice. Teratology 29 (3):411–16. doi:10.1002/tera.1420290312.
  • Kimmel, C. A., and J. G. Wilson. 1973. Skeletal deviations in rats: malformations or variations? Teratology 8 (3):309–15. doi:10.1002/tera.1420080311.
  • Kubola, J., and S. Siriamornpun. 2008. Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitro. Food Chem. 110:881–90. doi:10.1016/j.foodchem.2008.02.076.
  • Kumar, D. S., K. V. Sharathnath, P. Yogeswaran, A. Harani, K. Sudhakar, P. Sudha, and D. Banji. 2010. A medicinal potency of Momordica charantia. Int. J. Pharm. Sci. Rev. Res. 1:95–100.
  • Lederman, S. A., and P. Rosso. 1981. Effects of obesity, food restriction and pregnancy on fetal and maternal weight and on body composition in rats. J. Nutr. 111 (12):2162–71. doi:10.1093/jn/111.12.2162.
  • Lee, H. H., J. -W. Jang, J. K. Lee, and C. -K. Park. 2020. Rutin improves bone histomorphometric values by reduction of osteoclastic activity in osteoporosis mouse model induced by bilateral ovariectomy. J. Korean. Neurosurg. Soc. 63 (4):433–43. doi:10.3340/jkns.2019.0097.
  • Li, C. J., S. F. Tsang, C. H. Tsai, H. Y. Tsai, J. H. Chyuan, and H. Y. Hsu. 2012. Momordica charantia extract induces apoptosis in human cancer cells through caspase- and mitochondria-dependent pathways. Evid. Based Complement Alternat Med 2012:261971. doi:10.1155/2012/261971.
  • Lumey, L. H., and A. D. Stein. 1997. Offspring birth weights after maternal intrauterine undernutrition: A comparison within sibships. Am. J. Epidemiol. 146 (10):810–19. doi:10.1093/oxfordjournals.aje.a009198.
  • Mahamat, O., H. Flora, C. Tume, and A. Kamanyi. 2020. Immunomodulatory activity of Momordica charantia L. (Cucurbitaceae) leaf diethyl ether and methanol extracts on Salmonella typhi-infected mice and LPS-induced phagocytic activities of macrophages and neutrophils. Evid. Based Complement Alternat Med. 2020:5248346. doi:10.1155/2020/5248346.
  • Makris, S. L., H. M. Solomon, R. Clark, K. Shiota, S. Barbellion, J. Buschmann, M. Ema, M. Fujiwara, K. Grote, K. P. Hazelden, et al. 2009. Terminology of developmental abnormalities in common laboratory mammals (version 2). Reprod. Toxicol. 28 (3):371–434. doi:10.1016/j.reprotox.2009.06.010.
  • Manson, J. M., H. Zenick, and R. D. Costlow. 1982. Teratology test methods for laboratory animals. In Principles and methods of toxicology, ed. A. W. Hayes, pp. 141–84. New York: Raven Press.
  • Matos, F. J. A. 2009. Introdução a fitoquímica experimental. 3 ed. Fortaleza: UFC.
  • Ng, T. B., W. Y. Chan, and H. W. Yeung. 1992. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceae plants. Gen. Pharmacol. 23 (4):575–90. doi:10.1016/0306-3623(92)90131-3.
  • OECD. 2002. Test No. 423: acute oral toxicity - acute toxic class method. OECD Guidelines for the Testing of Chemicals, Section 4. Paris: OECD Publishing. doi:10.1787/9789264071001-en.
  • Ofuegbe, S. O., A. A. Oyagbemi, T. O. Omobowale, A. D. Adedapo, A. E. Ayodele, M. A. Yakubu, O. O. Oguntibeju, and A. A. Adedapo. 2020. Methanol leaf extract of Momordica charantia protects alloxan-induced hepatopathy through modulation of caspase-9 and interleukin-1β signaling pathways in rats. Vet. World 13 (8):1528–35. doi:10.14202/vetworld.2020.1528-1535.
  • Patil, S. A., and S. B. Patil. 2011. Toxicological studies of Momordica charantia Linn seed extracts in male mice. Int. J. Morphol. 29 (4):1212–18. doi:10.4067/S0717-95022011000400024.
  • Pitchakarn, P., S. Suzuki, K. Ogawa, W. Pompimon, S. Takahashi, M. Asamoto, P. Limtrakul, and T. Shirai. 2011. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett. 306 (2):142–50.
  • Pitchakarn, P., S. Suzuki, K. Ogawa, W. Pompimon, S. Takahashi, M. Asamoto, P. Limtrakul, and T. Shirai. 2012. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3. Food and Chemical Toxicology 50 (3–4):840–47.
  • Ramesh, P., R. Jagadeesan, S. Sekaran, A. Dhanasekaran, and S. Vimalraj. 2021. Flavonoids: classification, function, and molecular mechanisms involved in bone remodelling. Front Endocrinol. 12:779638. doi:10.3389/fendo.2021.779638.
  • Robert, E., C. Francannet, and G. Shaw. 1995. Neural tube defects and maternal weight reduction in early pregnancy. Reprod. Toxicol. 9 (1):57–59. doi:10.1016/0890-6238(94)00056-3.
  • Rocha, J. D., F. M. Carneiro, A. S. Fernandes, J. M. Morais, L. L. Borges, L. Chen-Chen, L. M. Almeida, and E. F. L. C. Bailão. 2022. Toxic potential of Cerrado plants on different organisms. Int. J. Mol. Sci. 23 (7):3413. doi:10.3390/ijms23073413.
  • Rolim, A., C. P. Maciel, T. M. Kaneko, V. O. Consiglieri, I. M. Salgado-Santos, and M. V. Velasco. 2005. Validation assay for total flavonoids, as rutin equivalents, from Trichilia catigua Adr Juss (Meliaceae) and Ptychopetalum Olacoides Bentham (Olacaceae) Commercial Extract. J AOAC Int 88:1015–19.
  • Saksena, S. K. 1971. Study of antifertility activity of the leaves of Momordica linn (Karela). Indian J. Physiol. Pharmacol. 15 (2):79–80.
  • Santos, K. K. A., E. F. F. Matias, C. E. Sobral-Souza, S. R. Tintino, M. F. B. Morais-Braga, G. M. M. Guedes, F. A. V. Santos, A. C. A. Sousa, M. Rolón, C. Vega, et al. 2012. Trypanocide, cytotoxic, and antifungal activities of Momordica charantia. Pharm. Biol. 50 (2):162–66. doi:10.3109/13880209.2011.581672.
  • Shanker, K., J. Naradala, G. K. Mohan, G. S. Kumar, and P. L. Pravallika. 2017. A sub-acute oral toxicity analysis and comparative in vivo anti-diabetic activity of zinc oxide, cerium oxide, silver nanoparticles, and Momordica charantia in streptozotocin-induced diabetic Wistar rats. RSC Adv. 7:37158–67. doi:10.1039/C7RA05693A.
  • Solecki, R., B. Bergmann, H. Bürgin, J. Buschmann, R. Clark, A. Druga, E. A. Van Duijnhoven, M. Duverger, J. Edwards, H. Freudenberger, et al. 2003. Harmonization of rat fetal external and visceral terminology and classification. report of the fourth workshop on the terminology in developmental toxicology, Berlin, 18-20 April 2002. Reprod. Toxicol. 17(5):625–37. doi:10.1016/s0890-6238(03)00092-3.
  • Sousa, W. C., A. T. S. Paz, J. D. Rocha, E. C. Conceição, L. M. Almeida, L. Chen-Chen, L. L. Borges, and E. F. L. C. Bailão. 2018. In vivo assessment of cyto/genotoxic, antigenotoxic and antifungal potential of Costus spiralis (Jacq.) Roscoe leaves and stems. An. Acad. Bras. Cienc. 90 (2):1565–77. doi:10.1590/0001-3765201720170714.
  • Sousa, H. G., V. T. Uchoa, S. M. G. Cavalcanti, P. M. Almeida, M. H. Chaves, J. S. L. Neto, P. H. M. Nunes, J. S. Costa, M. Rai, I. S. Carno, et al. 2021. Phytochemical screening, phenolic and flavonoid contents, antioxidant and cytogenotoxicity activities of Combretum leprosum Mart. (Combretaceae). J. Toxicol. Environ. Health Part A 84 (10):399–417. doi:10.1080/15287394.2021.1875345.
  • Srivastava, S., R. Bankar, and P. Roy. 2013. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. Phytomedicine 20 (8–9):683–90. doi:10.1016/j.phymed.2013.03.001.
  • Sun, L., X. Zhang, L. Dong, C. Zhang, P. Guo, and C. Wu. 2021. The triterpenoids of the bitter gourd (Momordica charantia) and their pharmacological activities: A review. Food Composit. Anal. 96:103726. doi:10.1016/j.jfca.2020.103726.
  • Svobodova, B., L. Barros, R. C. Calhelha, S. Heleno, M. J. Alves, S. Walcott, M. Bittova, V. Kuban, and I. C. F. R. Ferreira. 2017. Bioactive properties and phenolic profile of Momordica charantia L. medicinal plant growing wild in Trinidad and Tobago. Ind. Crops Prod. 95:365–73. doi:10.1016/j.indcrop.2016.10.046.
  • Tam, P. P. L., L. K. Law, and H. W. Yeung. 1984. Effects of alpha-momorcharin on preimplantation development in the mouse. J. Reprod. Fertil. 71 (1):33–38. doi:10.1530/jrf.0.0710033.
  • Tyl, R. W., and M. C. Marr. 2012. Developmental toxicity testing – methodology. In Developmental and reproductive toxicology – a practical approach, ed. R. D. HOOD, pp. 139–83. 3 ed. Boca Raton: CRC Press.
  • Uche-Nwachi, E. O., and C. McEwen. 2009. Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats. Afr. J. Tradit. Complement Altern Med. 7 (1):24–33. doi:10.4314/ajtcam.v7i1.57228.
  • Vimalraj, S., S. Saravanan, and R. Subramanian. 2021. Rutin-Zn(II) complex promotes bone formation - a concise assessment in human dental pulp stem cells and zebrafish. Chem. Biol. Interact. 349:109674. doi:10.1016/j.cbi.2021.109674.
  • Wang, Q. L., X. -C. Huo, J. -H. Wang, D. -P. Wang, Q. -L. Zhu, B. Liu, and L. -L. Xu. 2017. Rutin prevents the ovariectomy-induced osteoporosis in rats. Eur. Rev. Med. Pharmacol. Sci. 21 (8):1911–17.
  • Welly, R., M. Djamaludin, H. Sa’Adah, and S. Maharani. 2021. Subchronic toxicity of ethanol extract of bitter melon pulp (Momordica charantia L.) on liver function and histopathological changes in Wistar rats. Pharmacogn J. 13 (4):949–57. doi:10.5530/pj.2021.13.122.
  • Zhang, M., N. S. Hettiarachchy, R. Horax, P. Chen, and K. F. Over. 2009. Effect of maturity stages and drying methods on the retention of selected nutrients and phytochemicals in bitter melon (Momordica charantia) leaf. J. Food Sci. 74 (6):C441–448. doi:10.1111/j.1750-3841.2009.01222.x.
  • Zhang, J., Y. Huang, T. Kikuchi, H. Tokuda, N. Suzuki, K. Inafuku, M. Miura, S. Motohashi, T. Suzuki, and T. Akihisa. Cucurbitane triterpenoids from the leaves of Momordica charantia, and their cancer chemopreventive effects and cytotoxicities. Chem. Biodivers. 9:428–40. doi:10.1002/cbdv.201100142.
  • Zuanazzi, J. A. S., J. Á. Montanha, and S. M. Zucolotto. 2017. Flavonoides. In Farmacognosia: do produto natural ao medicamento, eds. C. M. O. Simões, E. P. Schenkel, J. C. P. Mello, L. A. Mentz, and P. R. Petrovick, pp. 209–33. São Paulo: Artmed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.